Saigon Hotel Corporation (HNX:SGH)
Vietnam · Delayed Price · Currency is VND 27,700
+1,300 (4.92%)
At close: Jul 17, 2025
Regulus Therapeutics Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 46,921 | 45,321 | 42,229 | 28,147 | 17,933 | 17,581 | Upgrade | |
Revenue Growth (YoY) | 9.21% | 7.32% | 50.03% | 56.95% | 2.00% | -61.31% | Upgrade |
Cost of Revenue | 24,625 | 24,355 | 22,957 | 18,514 | 15,638 | 16,555 | Upgrade |
Gross Profit | 22,296 | 20,966 | 19,272 | 9,633 | 2,296 | 1,026 | Upgrade |
Selling, General & Admin | 13,907 | 13,532 | 8,436 | 7,282 | 5,732 | 5,375 | Upgrade |
Operating Expenses | 13,907 | 13,532 | 8,436 | 7,282 | 5,732 | 5,375 | Upgrade |
Operating Income | 8,389 | 7,434 | 10,836 | 2,351 | -3,436 | -4,349 | Upgrade |
Interest & Investment Income | 5,508 | 5,935 | 10,924 | 8,924 | 8,689 | 9,527 | Upgrade |
Currency Exchange Gain (Loss) | 7.37 | 7.3 | 6.24 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -27.98 | -28.6 | -88.42 | -61.83 | -83.43 | -55.95 | Upgrade |
EBT Excluding Unusual Items | 13,876 | 13,348 | 21,677 | 11,213 | 5,170 | 5,123 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 135.5 | - | - | - | Upgrade |
Pretax Income | 13,876 | 13,348 | 21,813 | 11,213 | 5,170 | 5,123 | Upgrade |
Income Tax Expense | 2,837 | 2,718 | 4,393 | 2,268 | 744.08 | 731.88 | Upgrade |
Net Income | 11,040 | 10,630 | 17,420 | 8,944 | 4,426 | 4,391 | Upgrade |
Preferred Dividends & Other Adjustments | 1,453 | 1,453 | 2,132 | - | - | - | Upgrade |
Net Income to Common | 9,587 | 9,177 | 15,288 | 8,944 | 4,426 | 4,391 | Upgrade |
Net Income Growth | -33.76% | -38.98% | 94.76% | 102.10% | 0.80% | -77.12% | Upgrade |
Shares Outstanding (Basic) | 12 | 12 | 12 | 14 | 12 | 12 | Upgrade |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 14 | 12 | 12 | Upgrade |
Shares Change (YoY) | - | - | -13.47% | 15.58% | -0.04% | 0.03% | Upgrade |
EPS (Basic) | 775.37 | 742.25 | 1236.51 | 626.00 | 358.00 | 355.00 | Upgrade |
EPS (Diluted) | 775.12 | 742.00 | 1236.51 | 626.00 | 358.00 | 355.00 | Upgrade |
EPS Growth | - | -39.99% | 97.53% | 74.86% | 0.84% | -77.13% | Upgrade |
Free Cash Flow | 11,030 | 10,405 | 10,863 | 111,363 | -2,650 | 1,997 | Upgrade |
Free Cash Flow Per Share | 892.10 | 841.54 | 878.61 | 7794.03 | -214.33 | 161.45 | Upgrade |
Dividend Per Share | - | - | - | 400.000 | - | - | Upgrade |
Gross Margin | 47.52% | 46.26% | 45.64% | 34.22% | 12.80% | 5.84% | Upgrade |
Operating Margin | 17.88% | 16.40% | 25.66% | 8.35% | -19.16% | -24.74% | Upgrade |
Profit Margin | 20.43% | 20.25% | 36.20% | 31.78% | 24.68% | 24.97% | Upgrade |
Free Cash Flow Margin | 23.51% | 22.96% | 25.72% | 395.65% | -14.77% | 11.36% | Upgrade |
EBITDA | 10,920 | 10,020 | 13,644 | - | - | - | Upgrade |
EBITDA Margin | 23.27% | 22.11% | 32.31% | - | - | - | Upgrade |
D&A For EBITDA | 2,530 | 2,586 | 2,808 | - | - | - | Upgrade |
EBIT | 8,389 | 7,434 | 10,836 | 2,351 | -3,436 | -4,349 | Upgrade |
EBIT Margin | 17.88% | 16.40% | 25.66% | 8.35% | -19.16% | -24.74% | Upgrade |
Effective Tax Rate | 20.44% | 20.36% | 20.14% | 20.23% | 14.39% | 14.29% | Upgrade |
Revenue as Reported | 46,921 | 45,321 | 42,229 | 28,147 | 17,933 | 17,581 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.